Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Keep informed on insider trading with our comprehensive news coverage. Explore the latest insider stock trades, follow insider trading activity, and dive into detailed reports on recent cases. Whether you’re monitoring the markets or interested in today’s top headlines, our insider trades tracker provides timely insights and updates.
Kenneth P. Gianella, Chief Monetary Officer of Quantum Corp (NASDAQ:QMCO), bought 1,487 shares of the corporate’s widespread inventory on January 16, 2025. The shares have been bought at a worth of $35.68 every, totaling $53,056. The transaction comes amid Quantum’s…
Nicholas S. Schorsch, a big shareholder and the only managing member of Bellevue Capital Companions (WA:CPAP), LLC, has been actively rising his stake within the firm. The purchases had been made not directly via Bellevue Capital Companions and associated entities,…
Henk Jan Spanjaard, the Chief Income Officer of Quantum Corp (NASDAQ:QMCO), not too long ago bought a portion of his holdings within the firm. In keeping with a current SEC submitting, Spanjaard bought 935 shares of Quantum Corp’s frequent inventory…
Quantum Corp CEO James Lerner sells $89,592 in inventory
Marvell expertise CFO Willem Meintjes sells $177,495 in inventory
Santa Clara, CA – On January 15, Mark Casper, Government Vice President and Chief Authorized Officer at Marvell (NASDAQ:MRVL) Expertise, Inc. (NASDAQ:MRVL), executed a sequence of inventory transactions, culminating in a major sale on January 17. In keeping with a…
CAMBRIDGE, Mass.—Brian DeSchuytner, the Senior Vice President, Chief Working Officer, and Chief Monetary Officer of Mersana Therapeutics, Inc. (NASDAQ:MRSN), just lately reported a transaction involving the corporate’s widespread inventory. On January 15, DeSchuytner bought 2,331 shares of Mersana inventory at…
CAMBRIDGE, MA—Mersana Therapeutics, Inc. (NASDAQ:MRSN) lately reported that Ashish Mandelia, the corporate’s Vice President and Chief Accounting Officer, executed a sale of frequent inventory. Based on the submitting, Mandelia offered 1,791 shares at a value of $0.63 per share, totaling…
CAMBRIDGE, MA—Timothy B. Lowinger, the Senior Vice President and Chief Scientific and Know-how Officer of Mersana Therapeutics, Inc. (NASDAQ:MRSN), lately reported a sale of firm inventory. Based on the newest SEC submitting, Lowinger offered 1,794 shares of frequent inventory on…
Mark Pearson (LON:PSON), President and CEO of Equitable Holdings, Inc. (NYSE:NYSE:EQH), just lately reported the sale of firm inventory valued at roughly $1.55 million. The transactions, which happened on January 15, concerned the sale of 29,000 shares at costs starting…
